obstructive sleep apnea, FDA and Zepbound

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
FDA says decongestant in many cold medicines doesn't work. So what does?
Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading ...
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Are The FDA’s New Regulations On Medical Devices Making A Difference?
With the FDA's new requirements for premarket submission and ongoing monitoring by medical device manufacturers in place, ...
US FDA revokes authorization for four COVID antibody drugs
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, ...
The Indianapolis Star6d
Which foods are considered 'healthy?' FDA issues new label criteria
"We know food labeling can be a powerful tool for change," James Jones, the FDA's deputy commissioner for human foods, said ...